News

Shares of health coverage company Centene (NYSE:CNC) fell 3% in the morning session after the company was downgraded by ...
Shares of health coverage company Centene (NYSE:CNC) fell 3.3% in the morning session after JPMorgan cut its price target on ...
In the second quarter, CVS Health CVS turned in 8% revenue growth, 2% adjusted operating profit growth, and roughly flat ...
Centene is responding by repricing plans for 2026 and focusing on cost controls while Medicare Advantage and Prescription ...
Centene (CNC) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of $0.68. This compares ...
Discover Centene Corporation's Q2 2025 earnings analysis, uncovering setbacks, repricing strategies, and plans for profitability restoration.
Centene represents a countercyclical investment opportunity in managed care, as it can benefit from economic downturns through increasing enrollment in its Medicaid and individual exchange products.
Analysts are estimating that Molina Healthcare will report an earnings per share (EPS) of $5.92. Investors in Molina ...
Wall Street analysts forecast that Centene (CNC) will report quarterly earnings of $0.68 per share in its upcoming release, pointing to a year-over-year decline of 71.9%. It is anticipated that ...
At the heart of the legal challenge are accusations that Centene and its top executives presented an overly rosy picture of the company's financial health and future prospects.
At the heart of the legal challenge are accusations that Centene and its top executives presented an overly rosy picture of the company's financial health and future prospects.
SAN FRANCISCO, July 15, 2025 /PRNewswire/ -- Healthcare giant Centene Corporation (NYSE: CNC), a prominent provider of government-sponsored and commercial healthcare services, finds itself ...